Rapid Screening by Cell-Based Fusion Assay for Identifying Novel Antivirals of Glycoprotein B-Mediated Herpes Simplex Virus Type 1 Infection

Abstract

Herpes simplex virus type 1 (HSV-1) is a causative agent for a variety of diseases. Although antiherpetic drugs such as acyclovir have been developed to inhibit virus replication through interaction with DNA kinases, their continuous administration leads to an increase in the frequency of drug-resistant HSV-1, which is an important clinical issue that requires urgent solution. Recently, we reported that the sialylated O-linked sugar T antigen (sTn) and its attached peptide region (O-glycosylated sTn peptide) derived from the HSV-1 glycoprotein B (gB) protein inhibited HSV-1 infection by specifically targeting paired immunoglobulin-like type 2 receptor alpha (PILRα) in vitro. In this study, to further identify novel inhibitors of gB-mediated HSV-1 infection in vitro, we established a cell-based fusion assay for rapid drug screening. Chinese hamster ovary (CHO) cells were transfected with expression plasmids for HSV-1 gB, gD, gH, and gL, and T7 RNA polymerase, and were designated as the effector cells. The CHO-K1 cells stably expressing PILRα were transfected with the expression plasmid for firefly luciferase under the T7 promoter, and were designated as the target cells. The effector and target cells were co-cultured, and luminescence was measured when both cells were successfully fused. Importantly, we found that cell-to-cell fusion was specifically inhibited by Oglycosylated sTn peptide in a dose dependent manner. Our results suggested that this virus-free cell-based fusion assay system could be a useful and promising approach to identify novel inhibitors of gB-mediated HSV-1 infection, and will aid in the development of antiviral therapeutic strategies for HSV-1-associated diseases.Key words cell-based fusion assay; drug screening; herpes simplex virus type 1; paired immunoglobulinlike type 2 receptor alpha Herpesviridae is a family of DNA viruses that consists of nine human viruses belonging to the alphaherpesviridae (herpes simplex virus (HSV)-1, HSV-2, and varicella-zoster virus), betaherpesviridae (cytomegalovirus (CMV)), human herpes virus ((HHV)-6A, HHV-6B, and HHV-7), and gammaherpesviridae (Epstein-Barr virus (EBV) and HHV-8) subfamilies.

A Novel Method to Titrate Herpes Simplex Virus-1 (HSV-1) Using Laser-Based Scanning of Near-Infrared Fluorophores Conjugated Antibodies

“…They are mainly based on reporter systems such as luciferase and/or fluorescent proteins and are aimed at identifying antivirals targeting the early steps of HSV infection (Zhu et al, 2010; Matza-Porges et al, 2014; Maeda et al, 2016). These methods generally require the use of reporter-expressing recombinant viruses or cell lines transfected to express a reporter protein under a specific viral promoter.…”

NSC23766 and Ehop016 Suppress Herpes Simplex Virus-1 Replication by Inhibiting Rac1 Activity

“…HSV-1 causes lifelong latent infection as it can exist in trigeminal ganglia 1,2) . HSV-1 infection also results in serious outcomes such as keratitis and encephalitis which can lead to infectious blindness or even death 3,4) .…”